Home / Uncategorized / GenSight Biologics Announces Publication of Positive Safety Data from Phase I/II Trial of GS010 in the JAMA Ophthalmology

GenSight Biologics Announces Publication of Positive Safety Data from Phase I/II Trial of GS010 in the JAMA Ophthalmology

Business Wire – PARIS — –Feb 12, 2019–Regulatory News:
Source: New feed

About bingpedia

Check Also

Surfer's lost Apple Watch survives six months at sea

MSN – It’s the Robinson Crusoe of Apple Watches. Source: New feed Related

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: